BioCentury
ARTICLE | Company News

Abcam to acquire Epitomics

March 6, 2012 1:25 AM UTC

Protein research tool supplier Abcam plc (LSE:ABC) will acquire Epitomics Inc. (Burlingame, Calif.) in a stock and cash deal valued at $155 million, net of Epitomics' $15 million in cash. The purchase...